SCHEMBL6708968

SCHEMBL6708968

Cn1c(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc2cccc(Br)c21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
GPR35 Q9HC97 11/20 0.36
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
GRM4 Q14833 1/20 0.33
DHODH Q02127 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713815 0.92 HIF1A (0.41) HIF1ANPSR1RXFP1GPR35KMT2A
SCHEMBL6712526 0.91 RXFP1 (0.39) HIF1ANPSR1RXFP1GPR35NPC1
SCHEMBL6710170 0.89 NPSR1 (0.43) HIF1ANPSR1RXFP1GPR35HPGD
SCHEMBL6710507 0.88 HIF1A (0.42) HIF1ANPSR1RXFP1GPR35KMT2A
SCHEMBL6710547 0.88 GRM4 (0.41) HIF1ANPSR1RXFP1NPC1RAB9A
SCHEMBL6713833 0.88 CXCR1 (0.34) HIF1ANPSR1RXFP1KMT2ALMNA
SCHEMBL6712008 0.88 HIF1A (0.40) HIF1ANPSR1RXFP1GPR35KMT2A
SCHEMBL6709198 0.87 HIF1A (0.38) HIF1ANPSR1RXFP1GPR35NPC1
SCHEMBL6711867 0.87 HIF1A (0.37) HIF1ANPSR1RXFP1GPR35KMT2A
SCHEMBL6707800 0.87 NPSR1 (0.37) HIF1ANPSR1RXFP1GPR35NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885NPSR1 2999/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.